Филтриране по Last updated date SelectСледПредиFrom - To Дата Крайна дата This week This month Last week Last month Category HumanCorporateVeterinaryHerbal Topic MedicinesCOVID-19PharmacovigilanceVaccinesReferralsPaediatricsRare diseasesRegulatory and procedural guidanceClinical trialsAdvanced therapiesData on medicinesCompliance and inspectionsInnovationResearch and developmentMedicine shortagesBiosimilarsSMEAntimicrobial resistanceGovernanceBrexitQuality of medicinesCorporateGeneric and hybrid medicinesEarly accessMedicines for use outside the EUFeesProduct informationScientific adviceMedical devicesMaximum residue limitMpoxBiologicalsScientific guidelinesVeterinary limited marketsCompassionate useCareersMedication errorParallel distributionPRIMEProcurement Diseases area Viral diseasesCancerImmune-system diseasesDiabetesNeurodegenerative diseasesCardiovascular diseasesHIV and AIDS Responsible body CHMP CVMP PRAC Management Board COMP PDCO CMDh HMPC CAT Patient safety Yes Leave this field blank Filter Резултати (3799) Sort by Last update date (new to old)Last update date (old to new)A-ZZ-A Leave this field blank How to ensure that novel analytic methods are fit for decision-making 2 October 2019NewsCorporate Change of name of liposomal medicines at high risk of medication errors 26 September 2019NewsHumanData on medicinesQuality of medicines EMA advises companies on steps to take to avoid nitrosamines in human medicines 26 September 2019Press releaseHumanData on medicinesReferrals Working parties for healthcare professionals and for patients and consumers elect new co-chairs 25 September 2019NewsHumanCorporate EMA’s work on new veterinary regulation advances 23 September 2019NewsVeterinary Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 16-19 September 2019 20 September 2019NewsHumanGeneric and hybrid medicinesMedicinesRare diseases Committee for Medicinal Products for Veterinary Use (CVMP) meeting of 10-12 September 2019 13 September 2019Press releaseVeterinary EMA to review ranitidine medicines following detection of NDMA 13 September 2019Press releaseHumanPharmacovigilanceQuality of medicinesReferrals EMA to provide guidance on avoiding nitrosamines in human medicines 13 September 2019Press releaseHumanPharmacovigilance Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 2-5 September 2019 6 September 2019NewsHumanPharmacovigilanceReferrals 1 … 95 96 97 98 99 Page 99 of 380 100 101 102 103 … 380
Change of name of liposomal medicines at high risk of medication errors 26 September 2019NewsHumanData on medicinesQuality of medicines
EMA advises companies on steps to take to avoid nitrosamines in human medicines 26 September 2019Press releaseHumanData on medicinesReferrals
Working parties for healthcare professionals and for patients and consumers elect new co-chairs 25 September 2019NewsHumanCorporate
Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 16-19 September 2019 20 September 2019NewsHumanGeneric and hybrid medicinesMedicinesRare diseases
Committee for Medicinal Products for Veterinary Use (CVMP) meeting of 10-12 September 2019 13 September 2019Press releaseVeterinary
EMA to review ranitidine medicines following detection of NDMA 13 September 2019Press releaseHumanPharmacovigilanceQuality of medicinesReferrals
EMA to provide guidance on avoiding nitrosamines in human medicines 13 September 2019Press releaseHumanPharmacovigilance
Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 2-5 September 2019 6 September 2019NewsHumanPharmacovigilanceReferrals